Literature DB >> 18094952

Chronic urticaria: recent advances.

Malcolm W Greaves1, Kian Teo Tan.   

Abstract

Chronic urticaria is an umbrella term, which encompasses physical urticarias, chronic "idiopathic" urticaria and urticarial vasculitis. It is important to recognize patients with physical urticarias as the investigation and treatment differs in important ways from patients with idiopathic chronic urticaria or urticarial vasculitis. Although relatively uncommon, urticarial vasculitis is an important diagnosis to make and requires histological confirmation by biopsy. Underlying systemic disease and systemic involvement, especially of the kidneys, should be sought. It is now recognized that chronic "idiopathic" urticaria includes a subset with an autoimmune basis caused by circulating autoantibodies against the high affinity IgE receptor (FceR1) and less commonly against IgE. Although the autologous serum skin test has been proven useful in prompting search for and characterization of circulating wheal-producing factors in chronic urticaria, its specificity as a screening test for presence of functional anti-FceR1 is low, and confirmation by demonstration of histamine-releasing activity in the patient's serum must be the benchmark test in establishing this diagnosis. Improved screening tests are being sought; for example, ability of the chronic urticaria patient's serum to evoke expression of CD 203c on donor human basophils is showing some promise. The strong association between autoimmune thyroid disease and autoimmune urticaria is also an area of ongoing research. Drug treatment continues to be centered on the H1 antihistamines, and the newer second-generation compounds appear to be safe and effective even in off-label dosage. Use of systemic steroids should be confined to special circumstances such as tapering regimens for acute flare-ups. Use of leukotriene antagonists is becoming popular, but the evidence for efficacy is conflicting. Cyclosporin is also effective and can be used in selected cases of autoimmune urticaria, and it is also effective in non-autoimmune cases, although less so.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094952     DOI: 10.1007/s12016-007-0038-3

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  64 in total

1.  Chronic urticaria as a manifestation of necrotizing venulitis.

Authors:  N A Soter
Journal:  N Engl J Med       Date:  1977-06-23       Impact factor: 91.245

Review 2.  EAACI/GA2LEN/EDF guideline: management of urticaria.

Authors:  T Zuberbier; C Bindslev-Jensen; W Canonica; C E H Grattan; M W Greaves; B M Henz; A Kapp; M M A Kozel; M Maurer; H F Merk; T Schäfer; D Simon; G A Vena; B Wedi
Journal:  Allergy       Date:  2006-03       Impact factor: 13.146

3.  Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria.

Authors:  Ronit Confino-Cohen; Dorit Aharoni; Arnon Goldberg; Irena Gurevitch; Andreas Buchs; Mordechai Weiss; Joshua Weissgarten; Micha J Rapoport
Journal:  J Allergy Clin Immunol       Date:  2002-02       Impact factor: 10.793

4.  Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients.

Authors:  A Leznoff; G L Sussman
Journal:  J Allergy Clin Immunol       Date:  1989-07       Impact factor: 10.793

5.  Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies.

Authors:  R A Sabroe; P T Seed; D M Francis; R M Barr; A K Black; M W Greaves
Journal:  J Am Acad Dermatol       Date:  1999-03       Impact factor: 11.527

6.  Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid.

Authors:  M L Pacor; G Di Lorenzo; R Corrocher
Journal:  Clin Exp Allergy       Date:  2001-10       Impact factor: 5.018

7.  Assessment of autoimmunity in patients with chronic urticaria.

Authors:  L J Tong; G Balakrishnan; J P Kochan; J P Kinét; A P Kaplan
Journal:  J Allergy Clin Immunol       Date:  1997-04       Impact factor: 10.793

8.  High prevalence of autoimmune urticaria in children with chronic urticaria.

Authors:  Luigia Brunetti; Ruggiero Francavilla; Vito L Miniello; Michael H Platzer; Domenica Rizzi; Maria Letizia Lospalluti; Lars K Poulsen; Lucio Armenio; Per Stahl Skov
Journal:  J Allergy Clin Immunol       Date:  2004-10       Impact factor: 10.793

9.  IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera.

Authors:  M Ferrer; E Luquin; A P Kaplan
Journal:  Allergy       Date:  2003-08       Impact factor: 13.146

10.  Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria.

Authors:  R A Sabroe; D M Francis; R M Barr; A K Black; M W Greaves
Journal:  J Allergy Clin Immunol       Date:  1998-10       Impact factor: 10.793

View more
  14 in total

1.  Re: Serum thyroid autoantibodies in patients with idiopathic either acute or chronic urticaria.

Authors:  E Antiga; W Volpi; P Fabbri; M Caproni
Journal:  J Endocrinol Invest       Date:  2010-03-25       Impact factor: 4.256

Review 2.  Chronic spontaneous urticaria: an autoimmune disease? A revision of the literature.

Authors:  Gabriele Di Lorenzo; Maria Stefania Leto-Barone; Simona La Piana; Aurelio Seidita; Giovam Battista Rini
Journal:  Clin Exp Med       Date:  2012-05-15       Impact factor: 3.984

Review 3.  Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications.

Authors:  Massimo Cugno; Angelo V Marzano; Riccardo Asero; Alberto Tedeschi
Journal:  Intern Emerg Med       Date:  2009-12-01       Impact factor: 3.397

Review 4.  [Infections and chronic spontaneous urticaria. A review].

Authors:  B Wedi; U Raap; D Wieczorek; A Kapp
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

5.  Autoimmune mechanisms in chronic idiopathic urticaria.

Authors:  Jonathon Posthumus; Adrienne Tiñana; Jonathan D Mozena; John W Steinke; Larry Borish
Journal:  J Allergy Clin Immunol       Date:  2012-06-12       Impact factor: 10.793

Review 6.  Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema.

Authors:  Katherine Altman; Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

7.  Real-world use of omalizumab in patients with chronic idiopathic/spontaneous urticaria in the United States.

Authors:  Jacqueline Eghrari-Sabet; Ellen Sher; Abhishek Kavati; Dominic Pilon; Maryia Zhdanava; Maria-Magdalena Balp; Patrick Lefebvre; Benjamin Ortiz; Jonathan A Bernstein
Journal:  Allergy Asthma Proc       Date:  2018-02-19       Impact factor: 2.587

8.  The role of focal infections in the pathogenesis of psoriasis and chronic urticaria.

Authors:  Paweł Łukasz Brzewski; Magdalena Spałkowska; Magdalena Podbielska; Joanna Chmielewska; Marta Wołek; Katarzyna Malec; Anna Wojas-Pelc
Journal:  Postepy Dermatol Alergol       Date:  2013-04-12       Impact factor: 1.837

9.  Chronic autoimmune urticaria: where we stand?

Authors:  C L Goh; K T Tan
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

10.  Urticaria and infections.

Authors:  Bettina Wedi; Ulrike Raap; Dorothea Wieczorek; Alexander Kapp
Journal:  Allergy Asthma Clin Immunol       Date:  2009-12-01       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.